
Opinion|Videos|July 23, 2024
Empowering Patients: Key Considerations for BTK Inhibitor Adherence
A conversation on how to empower patients and the considerations for BTK inhibitor adherence.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- What are the key considerations for educating and empowering patients about BTK inhibitors to support adherence for the course of long-term treatment?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
CMS Announces GENEROUS Model to Lower Medicaid Drug Prices
3
Adolescents, Young Adults Use AI Chatbots for Mental Health Advice
4
3 Studies Endocrinologists and Cardiologists Should Read Before AHA 2025
5















































